Kunle Odunsi

Kunle Odunsi

Roswell Park Comprehensive Cancer Center - Buffalo / United States
Medical and Health Sciences / Obstetrics and Gynecology
AD Scientific Index ID: 4607022
-
person_outline Kunle Odunsi's MOST POPULAR ARTICLES
1-) Safety and activity of anti–PD-L1 antibody in patients with advanced cancerJR Brahmer, SS Tykodi, LQM Chow, WJ Hwu, SL Topalian, P Hwu, ...New England Journal of Medicine 366 (26), 2455-2465, 201278162012
2-) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancerE Sato, SH Olson, J Ahn, B Bundy, H Nishikawa, F Qian, AA Jungbluth, ...Proceedings of the National Academy of Sciences 102 (51), 18538-18543, 200525542005
3-) Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancerJ Matsuzaki, S Gnjatic, P Mhawech-Fauceglia, A Beck, A Miller, T Tsuji, ...Proceedings of the National Academy of Sciences 107 (17), 7875-7880, 20108412010
4-) Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ...Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 20127982012
5-) The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and EomesoderminRR Rao, Q Li, K Odunsi, PA ShrikantImmunity 32 (1), 67-78, 20107482010